Izotropic Corporation (IZOZF) Corporate Presentation from NobleCon18News and Market Data on Izotropic CorporationNobleCon 18 Complete Rebroadcast
|
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌


Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌


5/4/2026
Energy
Release – Century Lithium Announces Management Appointments to Advance Angel Island Lithium Project, Nevada
Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) (“Century Lithium” or the “Company”) is pleased to announce the following management appointments. These individuals will reinforce the Company’s technical, environmental, and...
7 min read
‌


5/4/2026
Natural Resources
Release – Power Metallic intercepts 17.45 Meters of 9.47% CuEqRec¹ in Hole 26-094 and 39 Meters of 5.66% CuEqRec¹ in Hole 26-101 at Lion
Power Metallic Mines Inc. (the “Company” or “Power Metallic”) (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV1) is pleased to provide additional assays from its winter 2026 drill program.
...
7 min read
‌


5/4/2026
Natural Resources
Release – First Phosphate Receives Funds from Warrant Exercise and Streamlines Capitalization Table
First Phosphate Corp. (CSE: PHOS) (OTCQX: FRSPF) (OTCQX ADR: FPHOY) (FSE: KD0) (“First Phosphate” or the “Company”) is pleased to announce the receipt of $3,070,549 in gross proceeds upon the exercise of...
4 min read
‌


5/4/2026
Health
Release – Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) — Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across...
4 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.